Tweet
I am writing a paper on Sequencing Companies for a MBA course I am taking regarding entrepreneurship and my paper is focusing on start-up companies (specifically Helico's and Pacific Bio) and how these companies sequencing machines pares up relative to established companies such as Roche and Illumina. Can anyone provide me with some information relative to their own personal experiences using Sequencing machines revolving around RNA / DNA 3rd generation sequencing and how the companies above compare to one another? From the information I have studied so far, their seems to be an infinite amount of information out there regarding which company does what but I am in information overload since my background in this type of new technology is very limited. I am a Mechanical Engineer by trade and I do understand some of the basics regarding this type of technology but again, my understanding is very limited. I do appreciate any feedback or links that provide some type of analysis of these companies sequencing machines as well as any personal experiences that members have had with them. I will post this thread on the other company boards. Thanks in advance!
-
-
Originally posted by KenFlo1 View Post
Please don't spam multiple forums with the same post. -
NilShomer:
Sorry - did not mean to spam. I was not able to post this thread in the general area. Is there any way this thread could be brought under the SEQanswers > Sequencing Technologies/Companies general area? Again, my apologies..Comment
-
Kenflo,
We're all very excited for your homework assignment, but your entrance into the community with 6+ crossposts is not conducive to getting help. ( and frankly be glad that Nils the big softie found them first....)
Seems another great homework assignment would be to try to observe and understand a situation before jumping in. This site is filled with exactly what you seek, search a bit and read.
Also, carriage returns would be nice too.
Comment
-
-
Eco - with all due respect to you and nilshomer, I reposted my post on 4 (not 6) so again I do apologize. I do appreciate if you the members can help me out - I did not realize I could have posted my post via the general forum. Sorry again people...Comment
-
No worries. We're crabby about spam and people taking advantage of this community.
Comment
-
Poster from AAAS/Science Business Office
Hello Kenflo1:
This poster from the AAAS/Science Business Office is dated to 2007 and while there doesn't seem to be an updated version, it does include the companies mentioned in your query. The AAAS graphic may help with your focus on more recent events in the evolution of sequencing technology that can be tracked, for example, via the seqanswers.com discussion forums.
JoannComment
-
Nice Poster ...Comment
-
Update for writers of papers on sequencing companies
See:
The $100 Genome: Implication for the DoD (US Department of Defense)
Check out the graphics collection!Comment
-
Hey, fellas! I can agree with every word of this guy!Not all people are so gifted writers. Most of them are using essay writing company for a long time while studying. And I know one company that is professional in their case. You can check resumeedge.com/ website if you are looking for help in good paper writing.Comment
-
Data variability is still an issue in sequencing technologies despite the advances in reproducibility and accuracy of these platforms. But the problem does not originate in the sequencing itself, but in the previous steps, before the sample reaches the sequencer.
The first step is collection, followed by preservation and sample preparation for analysis. Most scientists overlook those steps, but not being careful might just be skewing the experiment’s results.
...06-02-2026, 10:05 AM -
With the launch of new single-cell sequencing platforms in 2026, the field stands at an exciting inflection point. This article surveys the most impactful advances in the field and discusses how they’re reshaping research in cancer, immunology, and beyond.
Introduction
Single-cell sequencing technologies have undergone remarkable advances over the past decade, transitioning from low-throughput experimental approaches to highly scalable platforms capable of...05-22-2026, 06:42 AM
Comment